{"id":"W2981451418","doi":"10.1016/j.jtho.2019.08.1582","title":"P2.04-77 Hyperprogression with Immunotherapy in Metastatic Non-Small Cell Lung Cancer: Hôpital Charles-LeMoyne Experience","year":2019,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Lung cancer; Immunotherapy; Internal medicine; Cancer; Retrospective cohort study; Oncology; Disease; Cancer immunotherapy; Pathological; Medical record","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002740384,0.0002049569,0.0002045539,0.0002498113,0.001000237,0.000712446,0.0001914005,0.000491649,0.003964318],"category_scores_gemma":[0.0009104533,0.00009213041,0.0002621628,0.0002883155,0.0003128794,0.0002464635,0.0003208215,0.0005800132,0.0007646395],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006609373,"about_ca_system_score_gemma":0.0006535623,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002843598,"about_ca_topic_score_gemma":0.003218689,"domain_scores_codex":[0.9998316,0.00003757471,0.000006082914,0.00002258601,0.00003341996,0.0000688266],"domain_scores_gemma":[0.9996305,0.00007840144,0.00002801537,0.00001801634,0.0000336162,0.0002114819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.0016671,0.001629244,0.5526899,0.0001661397,0.0001356329,0.2407872,0.002568105,0.0006494886,0.01062586,0.004248448,0.01957414,0.1652587],"study_design_scores_gemma":[0.000251656,0.003712982,0.5197775,0.0002963805,0.0001667215,0.3713444,0.003130569,0.0009654872,0.005513282,0.001508588,0.09326447,0.00006780476],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9707987,0.004408272,0.0002260062,0.002689288,0.0002604019,0.00003428418,0.0001340337,0.00002752768,0.02142157],"genre_scores_gemma":[0.9905514,0.001749008,0.000161411,0.0007791221,0.0003266698,0.00001742449,0.0001465076,0.00002185348,0.006246723],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003964318,"threshold_uncertainty_score":0.01326191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01437470016179225,"score_gpt":0.3762615743880267,"score_spread":0.3618868742262344,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}